RE: Good news17 Sep 2024 18:39
Uncle he has just stated his opinion.
There are a lot of opinions on AIM.
I will be ignoring his opinion as I expect will pharma companies and bigger investors. City brokers aren't much to be respected.
Same goes for any note imo.
AIM is an awful, but then the UK markets are in a hole.
Thankfully, Avacta have an American biased management team and trial.
Overall things have just got a lot better for the company.